— Strong Market Demand

One platform.
Enabling the range of surgical navigation..

Different instruments. Same tracking enablement. Simple integration. That’s why top tier. That’s why top-tier medical device and clinical imaging companies are partnering with FreeNav today.

Structural Heart

Electrophysiology

Oncology

Orthopedics

ENT

Robotics

Simulation

Urology

— New Clinical Applications

Tracking where it wasn't previously possible.

Explore the technology

Existing tracking solutions are too expensive and too difficult to integrate for most clinical use cases. Here's what becomes possible when that changes:

  • Targeted delivery of therapies, biologics, and drug-eluting agents
  • Measuring range of motion and tissue shift in real time
  • Increasing fidelity in diagnostic imaging workflows
  • Multi-point tracking along flexible tools and delivery systems
  • Medical training and simulation with realistic haptic feedback
  • Augmenting robotic-assisted surgery with external reference tracking

— Why OEM Teams Choose FreeNav

Three benefit areas
where wireless changes the math.

User-centric form factor

  • "Hand-held" Workflow simplicity
  • Reduced design trade-offs by eliminating internal wired sensors
  • Small tag footprint drives easier integration into instrumentation
  • Versatile form factor unlocks new diagnostic and therapeutic areas

Designed for manufacturability

  • Common EM tracking technology across product portfolios
  • Lower-cost, scalable consumables & expanding access to underserved markets
  • Decreased production cost and complexity
  • Easily sourced materials yield a more efficient supply chain

Workflow simplicity

  • Less setup time and complexity
  • Decreased noise interference
  • Fewer product failure modes
    Reduction or elimination of procedural fluoroscopy
  • Integration with your existing navigation system display

— Market Context

A $1.4B market today.
$3.4B by 2032.

Optical tracking leads today's clinical imaging market, but it requires line of sight.
By overcoming the cost and integration challenges that have held EM tracking back,
FreeNav is positioned to take share in a market optical alone can't fully serve.

$1.4B

Global EM Tracking (TAM, today)

The current market for EM tracking systems and sensors & still limited by the economics of wired integration

$3.4B

Projected by 2032

Growth unlocked when tracking becomes affordable to embed in more procedures.

7+

Clinical Specialties Targeted

Cardiovascular, EP, oncology, orthopedics, ENT, robotics, simulation, & new applications we haven't named.

Market size sourced via Verified Market Reports. Procedure volume estimates drawn from AHA Journals, PubMed/NCBI, Radiology (RSNA), and GlobalData.

Regulatory status: 

FreeNav wireless tracking system components are intended for integration into OEM products and have not individually gone through a regulatory approval process. It is the responsibility of the OEM customer or end-user to determine requirements per specific application and obtain appropriate approvals for intended use.

Don't see your application?
Tell us about it

We're actively scoping new use cases across rigid, flexible, and robotic instrument categories. If you have a tracking opportunity wired EM hasn't solved, we want to hear about it.

Scope Your Application How the Tech Works